|
Home : Unsafe Drugs : Avandia : Newsfeeds : Proprietary Web Technology Reveals Hostility and Anger Among Patients Towards Takeda Pharmaceutical’s ACTOS Diabetes Drug Proprietary Web Technology Reveals Hostility and Anger Among Patients Towards Takeda Pharmaceutical’s ACTOS Diabetes Drug
When Takeda launched a switch campaign in 2010 to capitalize on the issues with Avandia (GlaxoSmithKline’s Oral Type 2 Diabetes Medication), social media response was hostile. They believe ACTOS has not truly differentiated itself from Avandia ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




